Jeffrey E. Russel

Array ( [id] => 2897605 [patent_doc_number] => 05245008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-14 [patent_title] => 'Process for the purification of insulins by chromatography' [patent_app_type] => 1 [patent_app_number] => 7/754003 [patent_app_country] => US [patent_app_date] => 1991-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5139 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/245/05245008.pdf [firstpage_image] =>[orig_patent_app_number] => 754003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2977230 [patent_doc_number] => 05252558 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-12 [patent_title] => 'Pentapeptide having specific inhibiting effect on epidermal cell proliferation, the salts thereof, pharmaceutical compositions comprising the same and a process for the preparation of the pentapeptide and the pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 7/750330 [patent_app_country] => US [patent_app_date] => 1991-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4406 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/252/05252558.pdf [firstpage_image] =>[orig_patent_app_number] => 750330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3072746 [patent_doc_number] => 05336756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-09 [patent_title] => 'Process for crystalline cyclic lipopeptides' [patent_app_type] => 1 [patent_app_number] => 7/750379 [patent_app_country] => US [patent_app_date] => 1991-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2819 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/336/05336756.pdf [firstpage_image] =>[orig_patent_app_number] => 750379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3010761 [patent_doc_number] => 05276139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-04 [patent_title] => 'Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones' [patent_app_type] => 1 [patent_app_number] => 7/750148 [patent_app_country] => US [patent_app_date] => 1991-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11103 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/276/05276139.pdf [firstpage_image] =>[orig_patent_app_number] => 750148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3111586 [patent_doc_number] => 05414071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-09 [patent_title] => 'Human cytokine IL-9' [patent_app_type] => 1 [patent_app_number] => 7/750154 [patent_app_country] => US [patent_app_date] => 1991-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6585 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/414/05414071.pdf [firstpage_image] =>[orig_patent_app_number] => 750154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2892428 [patent_doc_number] => 05183660 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-02 [patent_title] => 'Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides' [patent_app_type] => 1 [patent_app_number] => 7/745496 [patent_app_country] => US [patent_app_date] => 1991-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7723 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/183/05183660.pdf [firstpage_image] =>[orig_patent_app_number] => 745496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2786016 [patent_doc_number] => 05102634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-07 [patent_title] => 'Method for purifying exhaust gas and apparatus' [patent_app_type] => 1 [patent_app_number] => 7/745960 [patent_app_country] => US [patent_app_date] => 1991-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4316 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/102/05102634.pdf [firstpage_image] =>[orig_patent_app_number] => 745960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2827955 [patent_doc_number] => 05116947 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-26 [patent_title] => 'Process for the preparation of retro-inverso peptides and new intermediates thereof' [patent_app_type] => 1 [patent_app_number] => 7/742873 [patent_app_country] => US [patent_app_date] => 1991-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5460 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/116/05116947.pdf [firstpage_image] =>[orig_patent_app_number] => 742873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2980154 [patent_doc_number] => 05252710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-12 [patent_title] => 'Process for manufacturing von Willebrand factor' [patent_app_type] => 1 [patent_app_number] => 7/739452 [patent_app_country] => US [patent_app_date] => 1991-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3219 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 441 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/252/05252710.pdf [firstpage_image] =>[orig_patent_app_number] => 739452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2955783 [patent_doc_number] => 05243027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-07 [patent_title] => 'Method of preparing angiotensin converting enzyme inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/737852 [patent_app_country] => US [patent_app_date] => 1991-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2274 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/243/05243027.pdf [firstpage_image] =>[orig_patent_app_number] => 737852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2932491 [patent_doc_number] => 05233023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-03 [patent_title] => 'Process for phosphate ester compounds of certain cyclohexapeptides' [patent_app_type] => 1 [patent_app_number] => 7/738058 [patent_app_country] => US [patent_app_date] => 1991-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7170 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/233/05233023.pdf [firstpage_image] =>[orig_patent_app_number] => 738058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3012235 [patent_doc_number] => 05281698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-25 [patent_title] => 'Preparation of an activated polymer ester for protein conjugation' [patent_app_type] => 1 [patent_app_number] => 7/734749 [patent_app_country] => US [patent_app_date] => 1991-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5903 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/281/05281698.pdf [firstpage_image] =>[orig_patent_app_number] => 734749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3087404 [patent_doc_number] => 05284937 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-08 [patent_title] => 'Process for the extraction and purification of human recombinant gamma interferon' [patent_app_type] => 1 [patent_app_number] => 7/734778 [patent_app_country] => US [patent_app_date] => 1991-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5312 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/284/05284937.pdf [firstpage_image] =>[orig_patent_app_number] => 734778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2930230 [patent_doc_number] => 05232911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-03 [patent_title] => 'Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent' [patent_app_type] => 1 [patent_app_number] => 7/734534 [patent_app_country] => US [patent_app_date] => 1991-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6114 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/232/05232911.pdf [firstpage_image] =>[orig_patent_app_number] => 734534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3074861 [patent_doc_number] => 05320840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-14 [patent_title] => 'Continuous release pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 7/734225 [patent_app_country] => US [patent_app_date] => 1991-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 53174 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/320/05320840.pdf [firstpage_image] =>[orig_patent_app_number] => 734225 [rel_patent_id] =>[rel_patent_doc_number] =>)